TITLE

Toxicity of isoniazid and rifampicin combination

AUTHOR(S)
Campbell, I A
PUB. DATE
July 1995
SOURCE
Thorax;Jul1995, Vol. 50 Issue 7, p814
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66075372

 

Related Articles

  • Isoniazid/rifampicin.  // Reactions Weekly;Feb2014, Vol. 1489 Issue 1, p21 

    The article presents a case study of a woman diagnosed with toxicity developed while receiving isoniazid/rifampicin.

  • Rifampicin/isoniazid/pyrazinamide/ethambutol.  // Reactions Weekly;4/14/2012, Issue 1397, p28 

    The article describes the case of a man who developed liver toxicity and witdrawal after receiving rifampicin, isoniazid, pyrazinamide and ethambutol for malaria.

  • Subchronic Toxicity of Human Immunodeficiency Virus and Tuberculosis Combination Therapies in B6C3F1 Mice. Rao, Ghanta N.; Lindamood, Charles; Heath, James E.; Farnell, Daniel R.; Giles, Herschell D. // Toxicological Sciences;1998, Vol. 45 Issue 1, p113 

    Combination therapy with anti-HIV drugs and opportunistic infection drugs is a common practice in treatment of AIDS patients. Although toxic effects of most individual therapies are known, the toxic potential of most combination therapies has not been established. To understand the toxic...

  • Assessment of in vivo antimalarial activity of rifampicin, isoniazide, and ethambutol combination therapy. Aditya, Nayak P.; Patankar, Swati; Madhusudhan, Basavaraj // Parasitology Research;May2010, Vol. 106 Issue 6, p1481 

    The existing armament of drugs for the treatment and prevention of malaria is inadequate due to development of resistance. In addition to this due to lack of economic enticement the rate of new drug development and new drug discovery in the segment of parasitic diseases is very low as compared...

  • Isoniazid Could Be Used for Antibiotic-loaded Bone Cement for Musculoskeletal Tuberculosis: An In Vitro Study. Han, Chang; Oh, Taegwon; Cho, Sang-Nae; Yang, Jae; Park, Kwan // Clinical Orthopaedics & Related Research;Jul2013, Vol. 471 Issue 7, p2400 

    Background: Antibiotic-loaded bone cement (ALBC) has been used in serious cases of musculoskeletal tuberculosis, but the type and amount of antibiotic that should be used in ALBC have not been determined. Questions/purposes: We therefore determined the (1) elution characteristics and (2)...

  • Isoniazid/rifampicin overdose.  // Reactions Weekly;3/16/2013, Issue 1444, p25 

    The article presents a case study of a 31-year-old man developed various toxicities after receiving isoniazid and rifampicin tablets.

  • Isoniazid/rifampicin.  // Reactions Weekly;Sep2014, Vol. 1519 Issue 1, p103 

    The article presents a case study of a 63-year-old mana diagnosed with acute toxic dystrophy after administering isoniazid and rifampicin.

  • Rifampicin/isoniazid/pyrazinamide.  // Reactions Weekly;02/09/2013, Issue 1438, p27 

    The article presents a case report of a 47 year old woman who developed hypersensitivity reaction on being treated with rifampicin/isoniazid/pyrazinamide (Rifater) combination while the interaction is primarily suspected to be associated with rifampicin.

  • Elevated gatifloxacin and reduced rifampicin concentrations in a single-dose interaction study amongst healthy volunteers. Helen McIlleron; Jennifer Norman; Thomas P. Kanyok; P. Bernard Fourie; John Horton; Peter J. Smith // Journal of Antimicrobial Chemotherapy (JAC);Dec2007, Vol. 60 Issue 6, p1398 

    Objectives Pharmacokinetic drug–drug interactions were investigated between the fluoroquinolone gatifloxacin and a fixed dose combination (FDC) of rifampicin, isoniazid and pyrazinamide. Patients and methods The single-dose pharmacokinetics of the four drugs was evaluated in an...

  • Cutting costs on mono-resistant tuberculosis diagnosis could eventually end up being more expensive. Rouzaud, F.; Robledo, J. // Indian Journal of Medical Microbiology;Oct2010, Vol. 28 Issue 4, p412 

    A letter to the editor is presented in response to the article "Combined drug medium with isoniazid and rifampicin for identification of mutli-drug resistant Mycobacterium tuberculosis," by S. Nalini and colleagues.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics